Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

April 2017

Insights

Interview
Prostate Cancer Treatment Varies Between General Population, Diagnosed Men
01/11/2019
JCP Editors
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
...
01/11/2019
Journal of Clinical Pathways
Interview
Christiana Care Health System Pioneers Clinical Pathways in the Tri-State Area
01/11/2019
Clinical pathways are not new, but their prominence has grown in recent years. An increased focus on value-based medical care1 has brought strategies that provide optimal treatment at a favorable cost to the...
Clinical pathways are not new, but their prominence has grown in recent years. An increased focus on value-based medical care1 has brought strategies that provide optimal treatment at a favorable cost to the...
...
01/11/2019
Journal of Clinical Pathways

Feature

From the Field
Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplant Program
04/11/2017
Belinda R Avalos, MD
Abstract: The Levine Cancer Institute (LCI) of the Carolinas HealthCare System was established in Charlotte, NC, in 2010 as a primary through quaternary referral center. The Department of Hematologic Oncology and...
Abstract: The Levine Cancer Institute (LCI) of the Carolinas HealthCare System was established in Charlotte, NC, in 2010 as a primary through quaternary referral center. The Department of Hematologic Oncology and...
...
04/11/2017
Journal of Clinical Pathways
Research Reports
Length of Stay and Costs of COPD: Analysis of Hospitalized Patients Treated With Arformoterol or Nebulized Short-Acting Beta2-Agonists
04/11/2017
Krithika Rajagopalan, PhD
Scott B Robinson, PhD
Frank R Ernst, PharmD, MS
Tina Hunter, PhD
Bernadette H Johnson, MBA
Vamsi K Bollu, PhD, MBA
Abstract: Hospitalization costs are substantial in chronic obstructive pulmonary disease (COPD). Little is known regarding the effect of long-acting beta2-agonists (LABAs) vs short-acting beta2-agonists (SABAs) on...
Abstract: Hospitalization costs are substantial in chronic obstructive pulmonary disease (COPD). Little is known regarding the effect of long-acting beta2-agonists (LABAs) vs short-acting beta2-agonists (SABAs) on...
...
04/11/2017
Journal of Clinical Pathways

Column

Clinical Pathways GPS
Preparing for Take-Off: Readying Older Adults for Flight
04/11/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Sevy Gambs, MBA, ALA, MSN-GR
Older adults are at risk for a host of potential medical issues while traveling, arising from cognitive impairments such as Alzheimer disease, dementia or psychiatric disorders, and chronic conditions such as...
Older adults are at risk for a host of potential medical issues while traveling, arising from cognitive impairments such as Alzheimer disease, dementia or psychiatric disorders, and chronic conditions such as...
Older...
04/11/2017
Journal of Clinical Pathways
Pharma Insights
The Clash: Treatment Advances and Value Measurements in Oncology
04/11/2017
Larry Blandford, PharmD
Jason Shafrin, PhD
Cancer has or will affect nearly every person at some point in their lives, either directly or indirectly. The fight against cancer is central to society; in recent years, treatment advances and prevention strategies...
Cancer has or will affect nearly every person at some point in their lives, either directly or indirectly. The fight against cancer is central to society; in recent years, treatment advances and prevention strategies...
Cancer...
04/11/2017
Journal of Clinical Pathways

News

Conference Coverage
Academy of Managed Care Pharmacy Annual Meeting
04/11/2017
JCP Editors
The Academy of Managed Care Pharmacy (AMCP) is the leading professional organization for practitioners invested in the development and implementation of value-based care pathways within the managed care setting....
The Academy of Managed Care Pharmacy (AMCP) is the leading professional organization for practitioners invested in the development and implementation of value-based care pathways within the managed care setting....
The...
04/11/2017
Journal of Clinical Pathways
Conference Coverage
ASCO Quality Care Symposium
04/11/2017
JCP Editors
Value-based medical care continues to gain traction in the oncology sphere, and tools for the developing, measuring, and implementing value measures in clinical practice are needed. The rapid introduction of new...
Value-based medical care continues to gain traction in the oncology sphere, and tools for the developing, measuring, and implementing value measures in clinical practice are needed. The rapid introduction of new...
...
04/11/2017
Journal of Clinical Pathways

Department

Research in Review
Neurofeedback Reduces Nerve Damage From Chemotherapy in Cancer Survivors
04/11/2017
JCP Editors
Chemotherapy-induced peripheral neuropathy (CIPN) may be significantly reduced by electroencephalogram (EEG) neurofeedback training, according to research published in Cancer (published online March 3, 2017;...
Chemotherapy-induced peripheral neuropathy (CIPN) may be significantly reduced by electroencephalogram (EEG) neurofeedback training, according to research published in Cancer (published online March 3, 2017;...
...
04/11/2017
Journal of Clinical Pathways
Research in Review
Leukemia Survival Outcomes Differ Between Sites of Care
04/11/2017
JCP Editors
Sites of care may help explain survival differences between children and adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), according to research published...
Sites of care may help explain survival differences between children and adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), according to research published...
Sites...
04/11/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Volume 3

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement